Holdings of iShares Global Healthcare ETF
iShares Trust · Original filing · Compare with another fund · Report an error
- Net assets
- 3.8B $ including 3.8B $ in equities, 99.6 %
- Positions
- 110 in 16 countries
- Top ten
- 47.8 % of net assets
- Filed on
- Jun 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 350,380 | 420.3M $ | 10.93 % |
| 2 | Johnson & Johnson | 1,066,210 | 270.8M $ | 7.04 % |
| 3 | AbbVie Inc | 782,552 | 196.9M $ | 5.12 % |
| 4 | UnitedHealth Group Inc | 406,604 | 169M $ | 4.40 % |
| 5 | Merck & Co Inc | 1,232,696 | 158.4M $ | 4.12 % |
| 6 | AstraZeneca PLC | 774,124 | 144.5M $ | 3.76 % |
| 7 | Roche Holding AG | 350,659 | 144.2M $ | 3.75 % |
| 8 | Novartis AG | 913,752 | 142.8M $ | 3.71 % |
| 9 | Amgen Inc | 269,382 | 97.5M $ | 2.54 % |
| 10 | Thermo Fisher Scientific Inc | 185,465 | 93M $ | 2.42 % |
| 11 | Abbott Laboratories | 869,383 | 78.9M $ | 2.05 % |
| 12 | Gilead Sciences Inc | 619,698 | 78.3M $ | 2.04 % |
| 13 | Novo Nordisk A/S | 1,590,597 | 76.4M $ | 1.99 % |
| 14 | Intuitive Surgical Inc | 176,770 | 70.3M $ | 1.83 % |
| 15 | Pfizer Inc | 2,844,791 | 68.5M $ | 1.78 % |
| 16 | CVS Health Corp | 636,864 | 65.9M $ | 1.71 % |
| 17 | Vertex Pharmaceuticals Inc | 126,687 | 62.9M $ | 1.64 % |
| 18 | Danaher Corp | 314,415 | 59.9M $ | 1.56 % |
| 19 | Bristol-Myers Squibb Co | 1,019,269 | 58.7M $ | 1.53 % |
| 20 | Stryker Corp | 172,214 | 54.2M $ | 1.41 % |
| 21 | GSK PLC | 2,023,757 | 53.1M $ | 1.38 % |
| 22 | Medtronic PLC | 640,826 | 50.1M $ | 1.30 % |
| 23 | Sanofi SA | 532,395 | 45.5M $ | 1.18 % |
| 24 | McKesson Corp | 59,976 | 45.3M $ | 1.18 % |
| 25 | Elevance Health Inc | 108,365 | 41.9M $ | 1.09 % |
| 26 | Cigna Group/The | 132,026 | 36.4M $ | 0.95 % |
| 27 | Boston Scientific Corp | 741,880 | 31.7M $ | 0.82 % |
| 28 | Regeneron Pharmaceuticals Inc | 49,855 | 31.1M $ | 0.81 % |
| 29 | HCA Healthcare Inc | 77,505 | 30.2M $ | 0.79 % |
| 30 | Argenx SE | 30,878 | 28.6M $ | 0.74 % |
| 31 | Cardinal Health Inc | 116,886 | 27.8M $ | 0.72 % |
| 32 | Cencora Inc | 97,108 | 27.5M $ | 0.71 % |
| 33 | EssilorLuxottica SA | 145,677 | 27.4M $ | 0.71 % |
| 34 | Bayer AG | 490,353 | 27.1M $ | 0.71 % |
| 35 | Hoya Corp | 166,900 | 26.9M $ | 0.70 % |
| 36 | Edwards Lifesciences Corp | 287,370 | 26M $ | 0.68 % |
| 37 | Takeda Pharmaceutical Co Ltd | 794,492 | 25.3M $ | 0.66 % |
| 38 | Humana Inc | 59,913 | 23.8M $ | 0.62 % |
| 39 | Lonza Group AG | 35,038 | 23.6M $ | 0.61 % |
| 40 | Galderma Group AG | 91,412 | 20.8M $ | 0.54 % |
| 41 | IDEXX Laboratories Inc | 39,363 | 20.7M $ | 0.54 % |
| 42 | Becton Dickinson & Co | 136,853 | 20.7M $ | 0.54 % |
| 43 | Haleon PLC | 4,426,055 | 20.4M $ | 0.53 % |
| 44 | Sandoz Group AG | 219,596 | 19.8M $ | 0.52 % |
| 45 | CSL Ltd | 242,225 | 19.3M $ | 0.50 % |
| 46 | Agilent Technologies Inc | 141,050 | 18.7M $ | 0.49 % |
| 47 | Waters Corp | 48,997 | 18.4M $ | 0.48 % |
| 48 | UCB SA | 60,174 | 18M $ | 0.47 % |
| 49 | Otsuka Holdings Co Ltd | 257,000 | 17.1M $ | 0.44 % |
| 50 | Alcon AG | 249,391 | 16.8M $ | 0.44 % |
| 51 | IQVIA Holdings Inc | 83,286 | 16.1M $ | 0.42 % |
| 52 | Biogen Inc | 73,693 | 15.9M $ | 0.41 % |
| 53 | Daiichi Sankyo Co Ltd | 945,800 | 15.2M $ | 0.40 % |
| 54 | Zoetis Inc | 209,235 | 15M $ | 0.39 % |
| 55 | Centene Corp | 234,154 | 15M $ | 0.39 % |
| 56 | Chugai Pharmaceutical Co Ltd | 319,000 | 14.7M $ | 0.38 % |
| 57 | GE HealthCare Technologies Inc | 227,041 | 14.5M $ | 0.38 % |
| 58 | ResMed Inc | 72,386 | 14.1M $ | 0.37 % |
| 59 | Veeva Systems Inc | 74,920 | 13.3M $ | 0.35 % |
| 60 | Dexcom Inc | 192,603 | 13M $ | 0.34 % |
| 61 | Mettler-Toledo International Inc | 10,070 | 12.9M $ | 0.33 % |
| 62 | West Pharmaceutical Services Inc | 35,258 | 12.7M $ | 0.33 % |
| 63 | MODERNA INC | 176,275 | 12.3M $ | 0.32 % |
| 64 | Astellas Pharma Inc | 902,175 | 12.1M $ | 0.31 % |
| 65 | Quest Diagnostics Inc | 55,247 | 11.7M $ | 0.30 % |
| 66 | Labcorp Holdings Inc | 40,926 | 11.5M $ | 0.30 % |
| 67 | Merck KGaA | 64,503 | 10.8M $ | 0.28 % |
| 68 | Koninklijke Philips NV | 389,268 | 10.6M $ | 0.28 % |
| 69 | STERIS PLC | 48,943 | 10.3M $ | 0.27 % |
| 70 | BeOne Medicines Ltd | 470,400 | 10.3M $ | 0.27 % |
| 71 | Terumo Corp | 738,100 | 10.1M $ | 0.26 % |
| 72 | Incyte Corp | 83,764 | 9.5M $ | 0.25 % |
| 73 | Fresenius SE & Co KGaA | 205,213 | 9.4M $ | 0.24 % |
| 74 | VIATRIS INC | 581,305 | 9.2M $ | 0.24 % |
| 75 | Celltrion Inc | 78,987 | 8.9M $ | 0.23 % |
| 76 | Genmab A/S | 31,497 | 8.6M $ | 0.22 % |
| 77 | Zimmer Biomet Holdings Inc | 97,035 | 8.4M $ | 0.22 % |
| 78 | Straumann Holding AG | 56,502 | 7.4M $ | 0.19 % |
| 79 | Cooper Cos Inc/The | 97,386 | 7M $ | 0.18 % |
| 80 | Shionogi & Co Ltd | 400,100 | 6.8M $ | 0.18 % |
| 81 | Revvity Inc | 55,678 | 6.2M $ | 0.16 % |
| 82 | Smith & Nephew PLC | 425,596 | 6.2M $ | 0.16 % |
| 83 | Roche Holding AG | 14,375 | 6M $ | 0.16 % |
| 84 | Sonova Holding AG | 24,693 | 5.9M $ | 0.15 % |
| 85 | Olympus Corp | 556,600 | 5.8M $ | 0.15 % |
| 86 | Siemens Healthineers AG | 146,374 | 5.7M $ | 0.15 % |
| 87 | Solventum Corp | 73,449 | 5.7M $ | 0.15 % |
| 88 | Align Technology Inc | 33,234 | 5.6M $ | 0.15 % |
| 89 | Charles River Laboratories International Inc | 24,358 | 5.5M $ | 0.14 % |
| 90 | Bio-Techne Corp | 78,139 | 5.5M $ | 0.14 % |
| 91 | Baxter International Inc | 257,770 | 5.5M $ | 0.14 % |
| 92 | Sigma Healthcare Ltd | 2,880,750 | 5.5M $ | 0.14 % |
| 93 | Insulet Corp | 34,841 | 5.3M $ | 0.14 % |
| 94 | Fresenius Medical Care AG | 103,970 | 4.7M $ | 0.12 % |
| 95 | Eurofins Scientific SE | 56,994 | 4.5M $ | 0.12 % |
| 96 | Henry Schein Inc | 49,156 | 4.1M $ | 0.11 % |
| 97 | QIAGEN NV | 103,225 | 4M $ | 0.10 % |
| 98 | Universal Health Services Inc | 26,223 | 3.9M $ | 0.10 % |
| 99 | Eisai Co Ltd | 145,900 | 3.7M $ | 0.10 % |
| 100 | Sonic Healthcare Ltd | 246,680 | 3.5M $ | 0.09 % |
Sector breakdown
- Health care 88.4 %
- Consumer staples 0.5 %
- Technology 0.3 %
- Unattributed 10.7 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 71.2 %
- CHF 10.1 %
- GBP 5.9 %
- EUR 5.3 %
- JPY 3.7 %
- DKK 2.3 %
- AUD 0.8 %
- HKD 0.3 %
- KRW 0.2 %
- BRL 0.1 %
- SEK 0.1 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 71.3 %
- Switzerland 10.1 %
- United Kingdom 5.9 %
- Japan 3.7 %
- Denmark 2.3 %
- France 2.0 %
- Germany 1.6 %
- Belgium 1.2 %
- Australia 0.8 %
- Netherlands 0.3 %
- Hong Kong SAR China 0.3 %
- South Korea 0.2 %
- Other countries 0.3 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 61 | 2.7B $ | 71.34 % |
| 2 | Switzerland | 9 | 387.4M $ | 10.12 % |
| 3 | United Kingdom | 4 | 224.2M $ | 5.86 % |
| 4 | Japan | 11 | 141.2M $ | 3.69 % |
| 5 | Denmark | 3 | 88.5M $ | 2.31 % |
| 6 | France | 3 | 75.7M $ | 1.98 % |
| 7 | Germany | 6 | 61M $ | 1.59 % |
| 8 | Belgium | 2 | 46.6M $ | 1.22 % |
| 9 | Australia | 4 | 31.2M $ | 0.81 % |
| 10 | Netherlands | 1 | 10.6M $ | 0.28 % |
| 11 | Hong Kong SAR China | 1 | 10.3M $ | 0.27 % |
| 12 | South Korea | 1 | 8.9M $ | 0.23 % |
Cite this page
Titelia. "Holdings of iShares Global Healthcare ETF". https://titelia.com/en/funds/S000004372